Work

Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test

Year: 2001

Type: article

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1016/s0009-9236(01)78384-1

Authors: Kari Laine, Gunnel Tybring, Sebastian Härtter, Katarina Andersson RN, Jan‐Olof Svensson, Jolanta Widén, Leif Bertilsson

Institutions: University of Turku, Karolinska Institutet

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2008998473

FWCI: 4.05

Cites: 53

Cited by: 99

Related to: 10